In this Thursday, Dec. 18, 2014 photo, scientist Christopher Kistler checks on experiments in AMBR250 bio-reactors in a laboratory at the Merck company facilities in Kenilworth, N.J. The bio-reactors allow a large number of experiments to be done in the lab at the same time. Merck reports quarterly financial results on Tuesday, July 28, 2015.
Merck tops Street 2Q forecasts despite lower sales, profit
by Research Team | Jul 29, 2015 | Health News | 0 comments